COMMUNIQUÉS West-GlobeNewswire

Strongbridge Biopharma plc Announces New Employment Inducement Awards

28/08/2018 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

28/08/2018 - 13:30

Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at 48 Months CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) [...]

Assembly Biosciences to Present at Upcoming Investor Conferences

28/08/2018 - 13:05

SAN FRANCISCO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), today announced that the company will be participating in the following upcoming investor conferences in September: Baird [...]

Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Management of Acne Vulgaris

28/08/2018 - 13:05

Lead Researcher Mark Steven Nestor, M.D., Ph.D. Presented the Results of the Study at the Practical Symposium Dermatology Conference August 9-12, 2018 PETALUMA, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sonoma [...]

Protech Home Medical Releases Third Quarter Financial Results

28/08/2018 - 13:04

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

Kymriah® (tisagenlecleucel, formerly CTL019) receives European Commission Approval

28/08/2018 - 13:00

Kymriah ® (tisagenlecleucel, formerly CTL019) receives European Commission Approval London, UK – 28 August 2018: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group [...]

AxoGen, Inc. to Present at the Morgan Stanley Global Healthcare Conference

28/08/2018 - 13:00

ALACHUA, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, chief [...]

Aleafia Posts Record Revenue in Q2 with 160,000 sq ft Niagara Greenhouse to be Fully Operational in Late 2018

28/08/2018 - 13:00

Annual growing capacity to reach 38,000 kg in early 2019 TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“ Aleafia “) or (the “ Company “), one of [...]

XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference

28/08/2018 - 13:00

EMERYVILLE, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announced today its Chief Executive Officer, Jim [...]

First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

28/08/2018 - 13:00

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints measuring Safety, and Cognitive and Functional Efficacy (ADAS [...]

PetVivo Holdings, Inc. Adds Daniel P. Collins, Ph.D. as Chief Science Officer

28/08/2018 - 13:00

MINNEAPOLIS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCPINK:PETV), an emerging biomedical device company, is pleased to announce the addition of Daniel P. Collins, Ph.D., as Chief Science Officer (CSO [...]

Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

28/08/2018 - 13:00

NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018

28/08/2018 - 13:00

CAMBRIDGE, Mass, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is [...]

EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences

28/08/2018 - 13:00

WATERTOWN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer

28/08/2018 - 13:00

SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that it has appointed Andrew Sassine as Interim Chief Financial Officer (CFO), [...]

Emerald Health Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

28/08/2018 - 13:00

VICTORIA, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Chris Wagner, Chief Executive Officer, will present a corporate [...]

Revive Therapeutics Provides Corporate Update

28/08/2018 - 13:00

TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”) , a specialty cannabis company focused on the research, development and [...]

Radient Technologies Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update

28/08/2018 - 13:00

EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce financial results for the first fiscal quarter ended June 30, 2018 [...]

Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101

28/08/2018 - 12:30

Cancer Discovery Features Reports of Early Clinical Trials of SD-101 in Lymphoma and Advanced Melanoma BERKELEY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced [...]